Related references
Note: Only part of the references are listed.Development and Validation of a Modified Eighth AJCC Staging System for Primary Pancreatic Neuroendocrine Tumors
Xu-Feng Zhang et al.
ANNALS OF SURGERY (2022)
Carboxypeptidase A1 (CPA1) Immunohistochemistry Is Highly Sensitive and Specific for Acinar Cell Carcinoma (ACC) of the Pancreas
Ria Uhlig et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2022)
Prognostic value of DAXX/ATRX loss of expression and ALT activation in PanNETs: is it time for clinical implementation? Comment
Ilaria Marinoni
GUT (2022)
Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size
Wenzel M. Hackeng et al.
GUT (2022)
Enterochromaffin-like Cell Hyperplasia-Associated Gastric Neuroendocrine Tumors May Arise in the Setting of Proton Pump Inhibitor Use The Need for a New Clinicopathologic Category
Rehan Rais et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2022)
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours
Kate Young et al.
GUT (2021)
Driver mutations occur frequently in metastases of well-differentiated small intestine neuroendocrine tumours
Kris G. Samsom et al.
HISTOPATHOLOGY (2021)
A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical Correlations
Hege Elvebakken et al.
NEUROENDOCRINOLOGY (2021)
Impacts of pembrolizumab therapy on immune phenotype in patients with high-grade neuroendocrine neoplasms
Alexander W. MacFarlane et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Synaptophysin expression in V600EBRAF-mutated advanced colorectal cancers identifies a new subgroup of tumours with worse prognosis
Matteo Fassan et al.
EUROPEAN JOURNAL OF CANCER (2021)
Biomarkers of Response to Etoposide-Platinum Chemotherapy in Patients with Grade 3 Neuroendocrine Neoplasms
Caroline Lacombe et al.
CANCERS (2021)
DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association
Vanessa Lakis et al.
COMMUNICATIONS BIOLOGY (2021)
Evaluation of the prognosis for N2 status in patients with small bowel neuroendocrine tumors
Sarah M. Wonn et al.
AMERICAN JOURNAL OF SURGERY (2021)
Challenges in High-grade Neuroendocrine Neoplasms and Mixed Neuroendocrine/Non-neuroendocrine Neoplasms
Stefano La Rosa
ENDOCRINE PATHOLOGY (2021)
Alkylating agent rechallenge in metastatic pancreatic neuroendocrine tumors
Ophelie De Rycke et al.
ENDOCRINE-RELATED CANCER (2021)
Risk factors for progression of appendiceal neuroendocrine tumours: low-stage tumours <5 mm appear to be overwhelmingly indolent and may merit a separate designation
Mushal Noor et al.
HISTOPATHOLOGY (2021)
An algorithmic approach utilizing CK7, TTF1, beta-catenin, CDX2, and SSTR2A can help differentiate between gastrointestinal and pulmonary neuroendocrine carcinomas
Sanhong Yu et al.
VIRCHOWS ARCHIV (2021)
Digestive Well-Differentiated Grade 3 Neuroendocrine Tumors: Current Management and Future Directions
Anna Pellat et al.
CANCERS (2021)
Prognostic factors of metastatic neuroendocrine carcinoma under first-line treatment with platinum etoposide with a focus on NEC score and Rb expression: Results from the multicentre RBNEC study of the Groupe d'Etude des Tumeurs Endocrines (GTE) and the ENDOCAN-RENATEN network
Julien Hadoux et al.
EUROPEAN JOURNAL OF CANCER (2021)
T-Cell Responses in Merkel Cell Carcinoma: Implications for Improved Immune Checkpoint Blockade and Other Therapeutic Options
Laura Gehrcken et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Prognostic features of gastro-entero-pancreatic neuroendocrine neoplasms in primary and metastatic sites: Grade, mesenteric tumour deposits and emerging novelties
Ketevani Kankava et al.
JOURNAL OF NEUROENDOCRINOLOGY (2021)
Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice?
Claudio Luchini et al.
CURRENT ONCOLOGY REPORTS (2021)
Immunotherapy for Non-melanoma Skin Cancer
Sophia Z. Shalhout et al.
CURRENT ONCOLOGY REPORTS (2021)
Clinicopathologic and Molecular Characteristics of Gastrointestinal MiNENs
Min-Kyung Yeo et al.
FRONTIERS IN ONCOLOGY (2021)
Independent somatic evolution underlies clustered neuroendocrine tumors in the human small intestine
Erik Elias et al.
NATURE COMMUNICATIONS (2021)
Insulinoma-associated protein 1(INSM1) is a superior marker for the diagnosis of gastroenteropancreatic neuroendoerine neoplasms: a meta-analysis
Qinghui Zhang et al.
ENDOCRINE (2021)
Neuroendocrine neoplasms of the appendix, colon and rectum
Marco Volante et al.
PATHOLOGICA (2021)
Alterations in Ki67 Labeling Following Treatment of Poorly Differentiated Neuroendocrine Carcinomas A Potential Diagnostic Pitfall
Monika Vyas et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2021)
SATB2 in neuroendocrine neoplasms: strong expression is restricted to well-differentiated tumours of lower gastrointestinal tract origin and is most frequent in Merkel cell carcinoma among poorly differentiated carcinomas
Andrew M. Bellizzi
HISTOPATHOLOGY (2020)
Gastroenteropancreatic High-Grade Neuroendocrine Neoplasms: Histology and Molecular Analysis, Two Sides of the Same Coin
Adele Busico et al.
NEUROENDOCRINOLOGY (2020)
High-Grade Progression Confers Poor Survival in Pancreatic Neuroendocrine Tumors
Johan Botling et al.
NEUROENDOCRINOLOGY (2020)
INSM1 Is a Highly Specific Marker of Neuroendocrine Differentiation in Primary Neoplasms of the Gastrointestinal Tract, Appendix, and Pancreas An Immunohistochemical Study of 179 Cases
Kelsey E. McHugh et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2020)
Insulinoma-associated Protein 1 (INSM1) Is a Better Marker for the Diagnosis and Prognosis Estimation of Small Cell Lung Carcinoma Than Neuroendocrine Phenotype Markers Such as Chromogranin A, Synaptophysin, and CD56
Rie Sakakibara et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)
Diagnostic Value of Insulinoma-Associated Protein 1 (INSM1) and Comparison With Established Neuroendocrine Markers in Pulmonary Cancers A Comprehensive Study and Review of the Literature
Johan Staaf et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2020)
Insulinoma-associated protein 1 (INSM1) is a robust marker for identifying and grading pancreatic neuroendocrine tumors
David Kim et al.
CANCER CYTOPATHOLOGY (2020)
Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Neuroendocrine Tumors: Results From the Phase II KEYNOTE-158 Study
Jonathan Strosberg et al.
CLINICAL CANCER RESEARCH (2020)
Assessment of ARX expression, a novel biomarker for metastatic risk in pancreatic neuroendocrine tumors, in endoscopic ultrasound fine-needle aspiration
Wenzel M. Hackeng et al.
DIAGNOSTIC CYTOPATHOLOGY (2020)
Homogeneous MMR Deficiency Throughout the Entire Tumor Mass Occurs in a Subset of Colorectal Neuroendocrine Carcinomas
Christoph Fraune et al.
ENDOCRINE PATHOLOGY (2020)
PRRT in high-grade gastroenteropancreatic neuroendocrine neoplasms (WHO G3)
Halfdan Sorbye et al.
ENDOCRINE-RELATED CANCER (2020)
Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you?
Andrew M. Bellizzi
HUMAN PATHOLOGY (2020)
Proton Pump Inhibitor Use, Hypergastrinemia, and Gastric Carcinoids-What Is the Relationship?
Denis M. McCarthy
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Specific Genomic Alterations in High-Grade Pulmonary Neuroendocrine Tumours with Carcinoid Morphology
Jerome Cros et al.
NEUROENDOCRINOLOGY (2020)
Mixed Neuroendocrine Non-Neuroendocrine Neoplasms: A Systematic Review of a Controversial and Underestimated Diagnosis
Melissa Frizziero et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Pembrolizumab for the treatment of programmed death-ligand 1-positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTE-028 study
Janice M. Mehnert et al.
CANCER (2020)
Ki-67 proliferation index in neuroendocrine tumors: Can augmented reality microscopy with image analysis improve scoring?
Swati P. Satturwar et al.
CANCER CYTOPATHOLOGY (2020)
Long Survival and Prolonged Remission after Surgery and Chemotherapy in a Metastatic Mismatch Repair Deficient Pancreatic Neuroendocrine Carcinoma with MLH1/PMS2 Immunodeficiency and Minimal Microsatellite Shift
Alessandro Vanoli et al.
ENDOCRINE PATHOLOGY (2020)
Pathologic Considerations in Gastroenteropancreatic Neuroendocrine Tumors
Andrew M. Bellizzi
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2020)
Well Differentiated Grade 3 Neuroendocrine Tumors of the Digestive Tract: A Narrative Review
Anna Pellat et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Histopathological Revision for Gastroenteropancreatic Neuroendocrine Neoplasms in Expert Centers: Does It Make the Difference?
Elettra Merola et al.
NEUROENDOCRINOLOGY (2020)
Critical appraisal of MGMT in digestive NET treated with alkylating agents
Louis de Mestier et al.
ENDOCRINE-RELATED CANCER (2020)
Looking into digestive mixed neuroendocrine - nonneuroendocrine neoplasms: subtypes, prognosis, and predictive factors
Silvia Uccella et al.
HISTOPATHOLOGY (2020)
Comparison of different anti-Ki67 antibody clones and hot-spot sizes for assessing proliferative index and grading in pancreatic neuroendocrine tumours using manual and image analysis
Roisin Owens et al.
HISTOPATHOLOGY (2020)
Gastric neuroendocrine tumours from long-term proton pump inhibitor users are indolent tumours with good prognosis
Vincent Q-H Trinh et al.
HISTOPATHOLOGY (2020)
Gastrointestinal neuroendocrine tumors in 2020
Monjur Ahmed
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2020)
Distinct DNA Methylation Signatures in Neuroendocrine Tumors Specific for Primary Site and Inherited Predisposition
Amit Tirosh et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Pancreatic neuroendocrine carcinoma G3 may be heterogeneous and could be classified into two distinct groups
Hiroki Tanaka et al.
PANCREATOLOGY (2020)
Immunohistochemical distinction of paragangliomas from epithelial neuroendocrine tumors-gangliocytic duodenal and cauda equina paragangliomas align with epithelial neuroendocrine tumors
Divya Mamilla et al.
HUMAN PATHOLOGY (2020)
Improving the accuracy of gastrointestinal neuroendocrine tumor grading with deep learning
Darshana Govind et al.
SCIENTIFIC REPORTS (2020)
Epigenetic landscape of pancreatic neuroendocrine tumours reveals distinct cells of origin and means of tumour progression
Annunziata Di Domenico et al.
COMMUNICATIONS BIOLOGY (2020)
Deaths of colon neuroendocrine tumors are associated with increasing metastatic lymph nodes and lymph node ratio
Changchun Xiao et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2020)
Concordance Between the Ki-67 Index Cutoff Value of 55% and Differentiation in Neuroendocrine Tumor and Neuroendocrine Carcinoma in Grade 3 Pancreatic Neuroendocrine Neoplasms
Huiying Shi et al.
PANCREAS (2020)
A novel risk-scoring system for predicting lymph node metastasis of rectal neuroendocrine tumors
Keigo Chida et al.
ANNALS OF GASTROENTEROLOGICAL SURGERY (2020)
Should immunohistochemical expression of mismatch repair (MMR) proteins and microsatellite instability (MSI) analysis be routinely performed for poorly differentiated colorectal neuroendocrine carcinomas?
Tu Vinh Luong et al.
ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS (2020)
Insulinoma-associated protein 1 (INSM1) is a sensitive and highly specific marker of neuroendocrine differentiation in primary lung neoplasms: an immunohistochemical study of 345 cases, including 292 whole-tissue sections
Sanjay Mukhopadhyay et al.
MODERN PATHOLOGY (2019)
O6-methylguanine-DNA methyltransferase (MGMT) status in neuroendocrine tumors: a randomized phase II study (MGMT-NET)
Annie Lemelin et al.
DIGESTIVE AND LIVER DISEASE (2019)
Immune checkpoint markers in gastroenteropancreatic neuroendocrine neoplasia
Florian Boesch et al.
ENDOCRINE-RELATED CANCER (2019)
Performance of DAXX Immunohistochemistry as a Screen for DAXX Mutations in Pancreatic Neuroendocrine Tumors
Jaclyn F. Hechtman et al.
PANCREAS (2019)
Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic Alterations
Michele Simbolo et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Loss of Menin Expression by Immunohistochemistry in Pancreatic Neuroendocrine Tumors Comparison Between Primary and Metastatic Tumors
Rashmi T. Samdani et al.
PANCREAS (2019)
Value of SATB2, ISL1, and TTF1 to differentiate rectal from other gastrointestinal and lung well-differentiated neuroendocrine tumors
Zhao Lian-Hua et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
Endoscopic, transanal, laparoscopic, and transabdominal management of rectal neuroendocrine tumors
Louis de Mestier et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Lesion-by-lesion correlation between uptake at FDG PET and the Ki67 proliferation index in resected pancreatic neuroendocrine tumors
Louis de Mestier et al.
DIGESTIVE AND LIVER DISEASE (2019)
The evolving (epi)genetic landscape of pancreatic neuroendocrine tumours
Christodoulos P. Pipinikas et al.
ENDOCRINE-RELATED CANCER (2019)
Neuroendocrine Differentiation, Microsatellite Instability, and Tumor-infiltrating Lymphocytes in Advanced Colorectal Cancer With BRAF Mutation
Nunzio Digiacomo et al.
CLINICAL COLORECTAL CANCER (2019)
Diagnostic accuracy of a panel of immunohistochemical and molecular markers to distinguish Merkel cell carcinoma from other neuroendocrine carcinomas
Thibault Kervarrec et al.
MODERN PATHOLOGY (2019)
NordiQC Assessments of Chromogranin A Immunoassays
Rasmus Roge et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2019)
Microenvironment and tumor inflammatory features improve prognostic prediction in gastro-entero-pancreatic neuroendocrine neoplasms
Massimo Milione et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2019)
Detection rate of unknown primary tumour by using somatostatin receptor PET/CT in patients with metastatic neuroendocrine tumours: a meta-analysis
Sara De Dosso et al.
ENDOCRINE (2019)
Somatostatinoma Presented as Double-Duct Sign
Ali Zakaria et al.
CASE REPORTS IN GASTROINTESTINAL MEDICINE (2019)
Ki67 proliferative index of the neuroendocrine component drives MANEC prognosis
Massimo Milione et al.
ENDOCRINE-RELATED CANCER (2018)
The Lymph Node Ratio Optimizes Staging in Patients with Small Intestinal Neuroendocrine Tumors
Lunpo Wu et al.
NEUROENDOCRINOLOGY (2018)
Correlation between MGMT promoter methylation and response to temozolomide-based therapy in neuroendocrine neoplasms: an observational retrospective multicenter study
Davide Campana et al.
ENDOCRINE (2018)
Alternative Lengthening of Telomeres and Loss of DAXX/ATRX Expression Predicts Metastatic Disease and Poor Survival in Patients with Pancreatic Neuroendocrine Tumors
Aatur D. Singhi et al.
CLINICAL CANCER RESEARCH (2017)
In-depth mutational analyses of colorectal neuroendocrine carcinomas with adenoma or adenocarcinoma components
Christine Woischke et al.
MODERN PATHOLOGY (2017)
Four Neuroendocrine Tumor Types and Neuroendocrine Carcinoma of the Duodenum: Analysis of 203 Cases
Alessandro Vanoli et al.
NEUROENDOCRINOLOGY (2017)
Genetic and epigenetic drivers of neuroendocrine tumours (NET)
Annunziata Di Domenico et al.
ENDOCRINE-RELATED CANCER (2017)
Colorectal mixed adenoneuroendocrine carcinomas and neuroendocrine carcinomas are genetically closely related to colorectal adenocarcinomas
Moritz Jesinghaus et al.
MODERN PATHOLOGY (2017)
Somatostatin receptor expression related to TP53 and RB1 alterations in pancreatic and extrapancreatic neuroendocrine neoplasms with a Ki67-index above 20%
Bjoern Konukiewitz et al.
MODERN PATHOLOGY (2017)
Whole-genome landscape of pancreatic neuroendocrine tumours
Aldo Scarpa et al.
NATURE (2017)
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pathology-Diagnosis and Prognostic Stratification
Aurel Perren et al.
NEUROENDOCRINOLOGY (2017)
Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma
Abir Salwa Ali et al.
PLOS ONE (2017)
Impact of Ki67 re-assessmentat time of disease progression in patients with pancreatic neuroendocrine neoplasms
Francesco Panzuto et al.
PLOS ONE (2017)
Role of PD-L1 expression as a biomarker for GEP neuroendocrine neoplasm grading
Elisabetta Cavalcanti et al.
CELL DEATH & DISEASE (2017)
INSM1 Demonstrates Superior Performance to the Individual and Combined Use of Synaptophysin, Chromogranin and CD56 for Diagnosing Neuroendocrine Tumors of the Thoracic Cavity
Lisa M. Rooper et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2017)
Rb Loss and KRAS Mutation Are Predictors of the Response to Platinum-Based Chemotherapy in Pancreatic Neuroendocrine Neoplasm with Grade 3: A Japanese Multicenter Pancreatic NEN-G3 Study
Susumu Hijioka et al.
CLINICAL CANCER RESEARCH (2017)
Alternative lengthening of telomeres and ATRX/DAXX loss can be reliably detected in FNAs of pancreatic neuroendocrine tumors
Christopher J. VandenBussche et al.
CANCER CYTOPATHOLOGY (2017)
Immunohistochemical Characterization of the Origins of Metastatic Well-differentiated Neuroendocrine Tumors to the Liver
Zhaohai Yang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2017)
The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more personalized approach to cancer staging
Mahul B. Amin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Grade Increases in Gastroenteropancreatic Neuroendocrine Tumor Metastases Compared to the Primary Tumor
Federica Grillo et al.
NEUROENDOCRINOLOGY (2016)
Heterogeneity of grade 3 gastroenteropancreatic neuroendocrine carcinomas: New insights and treatment implications
Nicola Fazio et al.
CANCER TREATMENT REVIEWS (2016)
MGMT expression predicts response to temozolomide in pancreatic neuroendocrine tumors
J. Cros et al.
ENDOCRINE-RELATED CANCER (2016)
Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis
Marta Tellez-Gabriel et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Liver Metastases of Small Intestine Neuroendocrine Tumors Ki-67 Heterogeneity and World Health Organization Grade Discordance With Primary Tumors
Chanjuan Shi et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2015)
The High-grade (WHO G3) Pancreatic Neuroendocrine Tumor Category Is Morphologically and Biologically Heterogenous and Includes Both Well Differentiated and Poorly Differentiated Neoplasms
Olca Basturk et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
O6-Methylguanine-DNA methyltransferase status in neuroendocrine tumours: prognostic relevance and association with response to alkylating agents
T. Walter et al.
BRITISH JOURNAL OF CANCER (2015)
Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms
M. Heetfeld et al.
ENDOCRINE-RELATED CANCER (2015)
Microsatellite unstable gastrointestinal neuroendocrine carcinomas: a new clinicopathologic entity
Nora Sahnane et al.
ENDOCRINE-RELATED CANCER (2015)
Loss of DAXX and ATRX Are Associated With Chromosome Instability and Reduced Survival of Patients With Pancreatic Neuroendocrine Tumors
Ilaria Marinoni et al.
GASTROENTEROLOGY (2014)
18F-Fluorodihydroxyphenylalanine PET/CT in Patients with Neuroendocrine Tumors of Unknown Origin: Relation to Tumor Origin and Differentiation
Alessio Imperiale et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Mixed Adenoneuroendocrine Carcinomas of the Gastrointestinal Tract: Targeted Next-Generation Sequencing Suggests a Monoclonal Origin of the Two Components
Maria Scardoni et al.
NEUROENDOCRINOLOGY (2014)
Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study
H. Sorbye et al.
ANNALS OF ONCOLOGY (2013)
A comparison of Ki-67 and mitotic count as prognostic markers for metastatic pancreatic and midgut neuroendocrine neoplasms
M. S. Khan et al.
BRITISH JOURNAL OF CANCER (2013)
Small Cell and Large Cell Neuroendocrine Carcinomas of the Pancreas are Genetically Similar and Distinct From Well-differentiated Pancreatic Neuroendocrine Tumors
Shinichi Yachida et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Clinicopathologic Study of 62 Acinar Cell Carcinomas of the Pancreas Insights Into the Morphology and Immunophenotype and Search for Prognostic Markers
Stefano La Rosa et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Ki-67 proliferative index predicts progression-free survival of patients with well-differentiated ileal neuroendocrine tumors
Deepti Dhall et al.
HUMAN PATHOLOGY (2012)
Effect of Tumor Heterogeneity on the Assessment of Ki67 Labeling Index in Well-differentiated Neuroendocrine Tumors Metastatic to the Liver: Implications for Prognostic Stratification
Zhaohai Yang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
Yuchen Jiao et al.
SCIENCE (2011)
Hormonally defined pancreatic and duodenal neuroendocrine tumors differ in their transcription factor signatures: expression of ISL1, PDX1, NGN3, and CDX2
Gratiana Hermann et al.
VIRCHOWS ARCHIV (2011)
Neuroendocrine Markers Expression in Pancreatic Serous Cystadenoma
Kazunori Kanehira et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2011)
The monoclonal anti-BCL10 antibody (clone 331.1) is a sensitive and specific marker of pancreatic acinar cell carcinoma and pancreatic metaplasia
Stefano La Rosa et al.
VIRCHOWS ARCHIV (2009)
Share Paper
